After 30+ years of clinical experience with clozapine, it is time for professional psychiatry to demand an end to this discriminatory clozapine REMS program.
Gilbert Honigfeld, PhD
Advertisement
Dr Honigfeld is a psychopharmacologist and clinical researcher who led the development of clozapine. He is also the author of Psychiatric Drugs: A Desk Reference.
Articles by Gilbert Honigfeld, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Accepts NDA for CTx-1301 for Treatment of ADHD
2
Exploring CBT Approaches for Chronic Insomnia in Adults: A Systematic Review and Network Meta-Analysis
3
Medical Morality vs Chatbot Morality
4
New Data on Lumateperone for Prevention of Relapse in Schizophrenia
5
